UCLB is the commercialisation company of UCL and its partner NHS Trusts. They bring to market truly world-leading, world-changing technologies, innovations that have a real and positive impact on people’s lives. UCLB the access point to the wealth of innovation and intellectual property emanating from UCL and partner hospitals including University College Hospital, Great Ormond Street Hospital, Royal Free Hospital and Moorfields Eye Hospital. They offer a number of services to assist the technology development process, from consultancy through to collaborative research, IP licensing and the creation of spinout companies and joint ventures to maximise the commercial potential of new discoveries, materials and processes.

Genentech is a biotechnology company that discovers, develops, manufactures, and commercializes medicines to treat patients with serious or life-threatening medical conditions. It creates multiple products on the market and a development pipeline. The company became a member of the Roche Group in 2009. As part of their merger agreement, Roche and Genentech combined their pharmaceutical operations in the United States. Genentech’s South San Francisco campus now serves as the headquarters for Roche pharmaceutical operations in the United States. Genentech’s Research and Early Development section operates as an independent center within Roche. Genentech was founded in 1976 by [Robert Swanson](https://www.crunchbase.com/person/robert-a-swanson) and [Herbert Boyer](https://www.crunchbase.com/person/herbert-w-boyer). It is headquartered in South San Francisco, C.A.

CeleCure OU engages in drug discovery and development of novel anticancer drugs. The firm offers pipeline products include SB101, an angiogenesis inhibitor, CC0101, a tumor cell specific growth inhibitor, and entry bodies, which are antibodies blocking intracellular proteins. It focuses on cancer and antibody technologies. The company was founded in 2002 and is headquartered in Tallinn Linn, Estonia.

Cangene is a fully integrated developer and manufacturer of immune therapeutics. Our first drug, WinRho® SDF, has been commercially available since 1980, and since then we have established a solid track record of developing and commercializing plasma-derived products that address multiple therapeutic areas. Our current product portfolio consists of purified, concentrated antibody preparations (hyperimmunes) with target applications in infectious disease, hematology, transplantation and biodefense. Four of our hyperimmune products are approved in the United States and/or Canada, and three products are included in the U.S. Strategic National Stockpile. We are committed to the safety and quality of our products, the service of our customers, and the interests of our shareholders.

Fidia Farmaceutici SpA manufactures pharmaceutical products. The firm's platform technology level is the chemical modification, development, and manufacturing of state-of-the-art pharmaceuticals and medical devices based on hyaluronan covering therapeutic categories. The company was founded in 1946 and is headquartered in Abano Terme, Italy.

FUJIFILM Wako Pure Chemical Corp. produces and wholesales clinical diagnostic reagents, electronic materials, and chemical products. The firm offers product information, laboratory chemicals, specialty chemicals, clinical diagnostic reagents and equipment. The company was founded in 1922 and is headquartered in Osaka, Japan.

F. Hoffmann-La Roche Ltd. manufactures pharmaceutical products. It offers pharmaceutical drugs, pharmaceutical instruments, and diagnostics solutions. The company was founded by Fritz Hoffmann-La Roche on October 1, 1896 and is headquartered in Basel, Switzerland.

Achira Labs is a immunodiagnostics company focussed on developing point-of-care diagnostics solutions for developing countries. Achira’s ACIX100 is a microfluidics platform which combines a plastic disposable cartridge containing dry reagents and a desktop reader instrument. ACIX100’s rapid turn around time, low costs and minimal infrastructure and manpower requirements make it very suitable for rural and semi-urban areas that are under-served by large centralised diagnostics labs. ACIX 100 has been clinically validated for 7 tests in thyroid and fertility, along with a large menu of tests including infectious diseases under development. Achira leverages its expertise to provide technological services to customers in the medical devices sector. Achira’s expertise includes microfluidics research and development, design and prototyping, instrumentation, assay development and manufacturing. Achira is a 35 person company with a strong R&D focus. Achira has raised funds from Catamaran Ventures, Grand Challenges Canada and BIRAC (Govt. of India). Achira was founded in 2009 and is based in Bangalore, India.

Symic OA ApS is a private company headquartered in Denmark. The firm engages in research and experimental development in biotechnology.

The United States Department of Veterans Affairs (VA) is a federal Cabinet-level agency that provides near-comprehensive healthcare services to eligible military veterans at VA medical centers and outpatient clinics located throughout the country; several non-healthcare benefits including disability compensation, vocational rehabilitation, education assistance, home loans, and life insurance; and provides burial and memorial benefits to eligible veterans and family members at 135 national cemeteries.

Seikagaku Corp. manufactures pharmaceuticals and medical devices with glycoconjugates; specifically, glycosaminoglycans (GAG) such as hyaluronic acid; as well as enzymes that act on GAG. It operates through the following segments: Pharmaceuticals and Limulus Amebocyte Lysate (LAL). The Pharmaceuticals segment develops and supplies intra-articular injections for improving joint functions, cross-linked hyaluronate hydrogel for knee osteoarthritis, opthalmic surgical aids, and surgical aids for endoscopic mucosal resection. The LAL segment manufactures and sells endotoxin-detecting reagents in Japan and overseas. The company was founded on June 2, 1947 and is headquartered in Tokyo, Japan.

Baxter Healthcare SA engages in the development, production, and sale of healthcare systems and products. It also acquires and manages participations in pharmaceutical-chemical firms. The company was founded on December 7, 2000 and is headquartered in Glattpark, Switzerland.

Suzhou Ark Biotechnology Co., Ltd., established on 2002-12-03, The scope of business includes the research of biopharmaceuticals and other various pharmaceuticals(Does not contain human stem cells,Development and application of genetic diagnosis and treatment technology),Engaged in relevant supporting services for the construction project of Suzhou Jiqi Fangzhou Gene Pharmaceutical Co., Ltd.;manufacturing pharmaceutical equipment,Testing equipment;Self-owned factory lease,property management;non-pharmaceutical,Wholesale of non-hazardous chemical biological reagent products and related supporting services(The above involves quotas,Commodities under license management and special management,According to the relevant regulations of the state).(Items subject to approval by law,Business activities can only be carried out after approval by relevant departments)

FUJIFILM Corp. engages in the provision of imaging and information solutions. Its offers photography equipment, supplies and services, optical devices, healthcare, high-performance materials, graphic systems, recording media, and industrial products. The company was founded on October 2, 2006 and is headquartered in Tokyo, Japan.

Emergent BioSolutions Canada, Inc. operates as a biopharmaceutical company that develops and manufactures immune therapeutic drugs. The company is headquartered in Winnipeg, Canada.